Clinical-stage biotechnology company using generative AI and automation to discover and develop therapeutics
Clinical-stage biotechnology company using generative AI and automation to discover and develop therapeutics. Its Pharma.AI platform connects biological target discovery, molecular design, and clinical-trial analysis, and supports an internal drug pipeline across cancer, fibrosis, inflammatory, metabolic, CNS, and aging-related diseases.